Stockscreener 앱 받기
527.44
2.57%
13.21
전일 마감가:
$514.23
열려 있는:
$516.34
하루 거래량:
905.35K
Relative Volume:
0.40
시가총액:
$195.97B
수익:
$44.56B
순이익/손실:
$6.72B
주가수익비율:
29.73
EPS:
17.7387
순현금흐름:
$6.29B
1주 성능:
+7.75%
1개월 성능:
+13.59%
6개월 성능:
+0.31%
1년 성능:
+17.39%
1일 변동 폭
$514.00
$530.00
1주일 범위
$490.25
$530.00
52주 변동 폭
$385.46
$643.99
써모 피셔 사이언티픽 Stock (TMO) Company Profile
명칭
Thermo Fisher Scientific Inc
전화
(781) 622-1000
주소
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
527.33 | 184.37B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
199.34 | 134.19B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
583.73 | 44.72B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
121.42 | 32.52B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
332.94 | 31.41B | 3.17B | 642.63M | 516.49M | 10.77 |
써모 피셔 사이언티픽 Stock (TMO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-27 | 개시 | DZ Bank | Buy |
| 2025-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-12-09 | 개시 | Goldman | Buy |
| 2025-12-08 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-02 | 재개 | Morgan Stanley | Overweight |
| 2025-12-01 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2025-09-11 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2025-08-19 | 개시 | William Blair | Outperform |
| 2025-07-24 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2025-07-11 | 업그레이드 | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | 다운그레이드 | UBS | Buy → Neutral |
| 2025-01-10 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | 개시 | Scotiabank | Sector Perform |
| 2024-10-14 | 개시 | Redburn Atlantic | Buy |
| 2024-10-01 | 개시 | Stephens | Overweight |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-03-18 | 재개 | Citigroup | Neutral |
| 2024-01-24 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2024-01-08 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | 개시 | HSBC Securities | Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-10-26 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | 개시 | Bernstein | Outperform |
| 2023-09-06 | 재개 | Citigroup | Buy |
| 2023-07-19 | 개시 | Raymond James | Outperform |
| 2023-07-19 | 재확인 | Robert W. Baird | Outperform |
| 2023-07-13 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | 재확인 | Barclays | Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-10-27 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2022-08-25 | 개시 | Credit Suisse | Neutral |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | 재개 | Barclays | Overweight |
| 2021-10-20 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-16 | 개시 | The Benchmark Company | Buy |
| 2021-03-18 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | 개시 | Barclays | Overweight |
| 2021-01-08 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-12-02 | 개시 | Goldman | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | 개시 | Atlantic Equities | Overweight |
| 2020-09-14 | 개시 | Morgan Stanley | Overweight |
| 2020-08-20 | 재개 | JP Morgan | Overweight |
| 2020-07-15 | 업그레이드 | Cleveland Research | Neutral → Buy |
| 2020-07-07 | 재확인 | Needham | Buy |
| 2020-04-23 | 재확인 | Needham | Buy |
| 2020-01-31 | 재확인 | Needham | Buy |
| 2020-01-22 | 개시 | Credit Suisse | Neutral |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-11-15 | 개시 | Stifel | Buy |
| 2019-07-25 | 재확인 | Needham | Buy |
| 2019-07-16 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2019-05-30 | 개시 | Wolfe Research | Outperform |
| 2019-05-23 | 재확인 | Needham | Strong Buy |
| 2019-04-22 | 재확인 | Needham | Strong Buy |
| 2019-04-16 | 재확인 | BofA/Merrill | Buy |
모두보기
써모 피셔 사이언티픽 주식(TMO)의 최신 뉴스
Barclays Adjusts Price Target on Thermo Fisher Scientific to $625 From $650, Maintains Overweight Rating - marketscreener.com
A Look At Thermo Fisher Scientific (TMO) Valuation After Recent Share Price Volatility - Yahoo Finance
Thermo Fisher Scientific’s PPD Clinical Research Business Collaborates with HealthVerity to Expand Real-World Data Capabilities - BioSpace
Thermo Fisher Scientific Inc (TMO) Shares Surge 3.6% -- What GF Score of 88 Tells Investors - GuruFocus
Thermo Fisher Scientific Inc. stock rises Monday, outperforms market - MarketWatch
Will Thermo Fisher (TMO) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Thermo Fisher Scientific’s PPD Clinical Research Business Collaborates with HealthVerity to Expand R - PharmiWeb.com
Small Molecule Innovator API CDMO Market Outlook, 2026-2033Lonza Group, Novo Holdings (Catalent) and Thermo Fisher Scientific Lead the Growing Industry - Yahoo Finance UK
TD Cowen lowers Thermo Fisher stock price target on valuation reset - Investing.com
Thermo Fisher Scientific, HealthVerity Partner to Expand Real-World Data Capabilities - Contract Pharma
Thermo Fisher Scientific Inc. and HealthVerity Collaborate To Expand Real-World Data Capabilities - marketscreener.com
TD Cowen Adjusts Price Target on Thermo Fisher Scientific to $625 From $683, Maintains Buy Rating - marketscreener.com
Allergy Diagnostic Market by Product & Service, Test Type, Allergen, End User - GlobeNewswire Inc.
Goldman Sachs Adjusts PT on Thermo Fisher Scientific to $610 From $650, Maintains Buy Rating - marketscreener.com
Thermo Fisher stock may benefit following collaboration with PRECISE - MSN
Thermo Fisher PRECISE SG100K Partnership Puts Valuation And Growth In Focus - Yahoo Finance
Wallace Advisory Group Reduces Stake in Thermo Fisher Scientific - National Today
Is It Too Late To Consider Thermo Fisher Scientific (TMO) After Recent Share Price Weakness? - Yahoo Finance
Thermo Fisher Launches Automated Cell Therapy System - Technology Networks
Thermo Fisher expands global biobank leadership through collaboration with PRECISE-SG100K Singapore - BioSpectrum Asia
Is Thermo Fisher Scientific (TMO) one of the best conservative stocks to buy right now? - MSN
The Market Is Selling Everything, but These 5 Stocks Aren’t Breaking Down - Investing.com
Thermo Fisher Stock May Benefit Following Collaboration With PRECISE - Yahoo Finance
Flow Cytometry Market is experiencing boost at an infinite speed - openPR.com
Global Next-Generation Sequencing (NGS) Market to Double in Size by 2030 - GlobeNewswire Inc.
Thermo Fisher Shares Could See Gains After Teaming Up With PRECISE - Bitget
Thermo Fisher Scientific Expands Global Biobank Leadership - National Today
Thermo Fisher Scientific and Precision Health Research Singapore Enter Strategic Collaboration to Advance Precise-SG100K Study - marketscreener.com
Thermo Fisher Scientific Expands Global Biobank Leadership Through Strategic Collaboration with PREC - PharmiWeb.com
Thermo Fisher, Singapore’s PRECISE Partner on Population-Scale Proteomics Biobank - Contract Pharma
Thermo Fisher Scientific Partners PRECISE To Advance Singapore’s Landmark SG100K Biobank Study - BioPharma APAC
TMO Partners with Precision Health for Major Biobank Study - GuruFocus
Thermo Fisher Scientific Signs Strategic Deal With Precision Health Research, Singapore to Support PRECISE-SG100K Study - marketscreener.com
Thermo Fisher partners with Singapore biobank study By Investing.com - Investing.com India
Seer Joins Thermo Fisher Tools In Large-Scale Proteomics Effort - Benzinga
Thermo Fisher Scientific Expands Global Biobank Leadership Through Strategic Collaboration with PRECISE-SG100K Singapore to Advance Population-Scale Proteomics - Business Wire
Thermo Fisher Saladax TDM Deal Adds Dimension To Diagnostics Growth Story - Yahoo Finance
How Investors May Respond To Thermo Fisher Scientific (TMO) Expanding Its Cell Therapy And Biologics Platforms - Sahm
Thermo Fisher Scientific Inc. stock rises Wednesday, outperforms market - MarketWatch
Thermo Fisher Scientific Inc. (TMO) stock price, news, quote and history - Yahoo Finance Singapore
Biotechnology Reagents and Kits Market Set to Witness Rapid - openPR.com
[ARS] THERMO FISHER SCIENTIFIC INC. SEC Filing - Stock Titan
Thermo Fisher (NYSE: TMO) outlines 2025 performance, CEO retention grant and 2026 pay overhaul - Stock Titan
Thermo Fisher (TMO) Poised for Growth with Upcoming Catalysts - GuruFocus
Lobbying Update: $21,000 of THERMO FISHER SCIENTIFIC INC lobbying was just disclosed - Quiver Quantitative
Thermo Fisher Introduces Gibco CTS Compleo Fill and Finish System - Contract Pharma
Electron Microscopes Market Is Going to Boom |• Thermo Fisher Scientific • JEOL Ltd. - openPR.com
Thermo Fisher Scientific Inc. $TMO Shares Sold by Rathbones Group PLC - MarketBeat
Biotech layoffs pick back up as 14 companies cut 745 jobs in Q1 - The Business Journals
JB Capital LLC Decreases Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Experiences Revision in Stock Evaluation Amid Market Volatility - Markets Mojo
써모 피셔 사이언티픽 (TMO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.69%
자본화:
|
볼륨(24시간):